Study of biomarkers to determine severity and lung damages in COVID-19 patients
The Journal of Infection in Developing Countries · 2024
DOI: 10.3855/jidc.19635 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infection in Developing Countries, 2024. Verfasst von Alfian Nur Rosyid und 8 weiteren Autor:innen. Beteiligte Einrichtung: Doctoral Program of Medical Science, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia. Hauptthemen laut MEDLINE: COVID-19, Biomarkers, Severity of Illness Index, Tissue Inhibitor of Metalloproteinase-1. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitas Airlangga.
Abstract (Originalsprache)
Introduction
Identifying inflammation and lung damage markers is crucial in reducing morbidity and mortality of coronavirus disease 2019 (COVID-19). This study aimed to examine the validity and reliability of severity and post-infection lung damage and analyse their relationship. Methodology: This was a prospective analysis study at the Airlangga University Hospital, Surabaya, Indonesia, from March to August 2021. The infection`s severity was measured by examining angiotensin-converting enzyme 2 (ACE2) levels and complete blood count. Lung damage was estimated by reviewing Krebs von de Lungen (KL)-6, matrix metalloproteinase (MMP)-9, tissue inhibitor metalloproteinase (TIMP)-1, and MMP-9/TIMP-1. Two-factor confirmatory factor analysis (CFA) and canonical correlation were calculated using Lisrel and SPSS (version 25).
Results
The research sample included 76 patients. The t count loading factor values were calculated: ACE2 (6.00), neutrophils (-0.80), lymphocytes (-0.63), neutrophil-lymphocyte ratio (NLR, 1.27), eosinophils (-1.52), basophils (1.72), monocytes (0.05), platelets (0.53), leukocytes (-0.51), platelet-lymphocyte ratio (PLR, -1.15), KL-6 (10.47), MMP-9 (11.91), TIMP-1 (11.79), and MMP-9/TIMP-1 (-0.24). The t values were: neutrophil covariance error (6.11), lymphocytes (6.12), NLR (6.10), eosinophils (6.08), basophils (6.07), monocytes (6.12), platelets (6.12), leukocytes (6.12), PLR (6.10), ACE2 (0.97), KL-6 (5.63), MMP-9 (2.08), TIMP-1 (2.77), and MMP-9/TIMP-1 (6.12). t value canonical correlation of 7.04 (t count > 1.96) indicated a correlation between the severity of the patient and post-infection lung damage.
Conclusions
The severity was adequately measured through ACE2, IL-6, IL-10, neutrophils, lymphocytes, leukocytes, and NLR. Lung damage was measured with KL-6, MMP-9, and TIMP-1. There was a correlation between disease severity and lung damage.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Doctoral Program of Medical Science, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.
- Universitas Airlangga Hospital, Surabaya, Indonesia.
- Department of Pulmonary and Respiratory Medicine, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.
Förderung
- Universitas Airlangga
Zitieren
APA
Rosyid, A. N., Puspitasari, A. D., Effendy, W. I., Setiawan, H. W., Bakhtiar, A., Marhana, I. A., Sensusiati, A. D., Nugraha, J., & Amin, M. (2024). Study of biomarkers to determine severity and lung damages in COVID-19 patients. The Journal of Infection in Developing Countries. https://doi.org/10.3855/jidc.19635
Vancouver
Rosyid AN, Puspitasari AD, Effendy WI, Setiawan HW, Bakhtiar A, Marhana IA, et al. Study of biomarkers to determine severity and lung damages in COVID-19 patients. The Journal of Infection in Developing Countries. 2024. doi:10.3855/jidc.19635
BibTeX
@article{Rosyid2024,
author = {Rosyid, Alfian Nur and Puspitasari, Arina Dery and Effendy, Wiwin Is and Setiawan, Herley Windo and Bakhtiar, Arief and Marhana, Isnin Anang and Sensusiati, Anggraini Dwi and Nugraha, Jusak and Amin, Muhammad},
title = {Study of biomarkers to determine severity and lung damages in COVID-19 patients},
journal = {The Journal of Infection in Developing Countries},
year = {2024},
doi = {10.3855/jidc.19635}
}
EUVIMED